Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication
Open accessThe DOI matches its Crossref record; 62 of the 67 references it cites were found in a registry or an index.
Abstract
Deregulation of cyclin D1 occurs in numerous human cancers through mutations, alternative splicing, and gene amplification. Although cancer-derived cyclin D1 mutants are potent oncogenes in vitro and in vivo, the mechanisms whereby they contribute to neoplasia are poorly understood. We now provide evidence derived from both mouse models and human cancer-derived cells revealing that nuclear accumulation of catalytically active mutant cyclin D1/CDK4 complexes triggers DNA rereplication, resulting from Cdt1 stabilization, which in turn triggers the DNA damage checkpoint and p53-dependent apoptosis. Loss of p53 through mutations or targeted deletion results in increased genomic instability and neoplastic growth. Collectively, the data presented reveal mechanistic insights into how uncoupling of critical cell cycle regulatory events will perturb DNA replication fidelity, thereby contributing to neoplastic transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, certain cyclin D mutants or C-terminally truncated variants encoded by an alternatively spliced mRNA (D1b) that lacks the Thr-286 codon are retained in the nucleus during S phase and are proposed to confer a neo-oncogenic function that triggers DNA re-replication, aneuploidy, and tumorigenesis (59-61).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438 · cited 2×
“previously by Rogakou et al. (1998). Soluble and chromatin frac-”
MethodSherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 2×
“…al. 1994; Herman et al. 1995; Barnes and Gillett 1998; Hibberts et al. 1999; Hosokawa et al. 1999; BaniHani et al. 2000; Hemmer et al. 2001; Ikeguchi et al. 2001; Jin et al. 2001); overexpression can result from gene amplification, chromosomal translocation, or protein stabilization (Sherr 1996).”
BackgroundCell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · cited 3×
“The deleterious effects of D1T286A-dependent DNA rereplication and genomic instability is initially opposed by p53-dependent apoptosis that occurs in response to DNA breaks, perturbations in DNA replication, and oncogene activation (Kastan and Bartek 2004).”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 3×
“…remains controversial, activation of the DNA damage checkpoint signaling pathway in preneoplastic tissue is consistent with the former (Bartkova et al. 2005; Gorgoulis et al. 2005) and suggests that initial “hits” trigger DNA damage and p53-dependent apoptosis to counter accumulation…”
BackgroundGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 1×
“Ras also contributes to the accumulation of the cyclin D1 protein, via a pathway involving PI3K and Akt, which attenuates the GSK3 kinase (Franke et al. 1995, 1997); GSK3 -dependent phosphorylation of cyclin D1 on Thr286 promotes cyclin D1 proteolysis (Diehl et al. 1998).”
BackgroundSelf-citationDNA Replication in Eukaryotic Cells
Bell, S. P., & Dutta, A. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135425 · Cited by 2,060 · cited 2×
“During G1 phase, DNA replication origins are established via loading of ORC (origin recognition complex) followed by Cdt1/CDC6-dependent loading of the replicative MCM helicase (Bell and Dutta 2002).”
BackgroundActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · cited 3×
“Recent work revealed induction of DNA damage in premalignant tissue (Bartkova et al. 2005; Gorgoulis et al. 2005), suggesting a mechanism whereby oncogenic stress in nonmalignant cells may provide selective pressure to delete p53 and promote tumorigenesis.”
BackgroundFranke, T. F., Yang, S.-I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,006 · cited 1×
“Ras also contributes to the accumulation of the cyclin D1 protein, via a pathway involving PI3K and Akt, which attenuates the GSK3 kinase (Franke et al. 1995, 1997); GSK3 -dependent phosphorylation of cyclin D1 on Thr286 promotes cyclin D1 proteolysis (Diehl et al. 1998).”
BackgroundOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 1×
“Recent work has correlated oncogene-induced senescence with induction of the DNA damage checkpoint in solid tumors (Bartkova et al. 2006; Di Micco et al. 2006).”
BackgroundOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 1×
“Recent work has correlated oncogene-induced senescence with induction of the DNA damage checkpoint in solid tumors (Bartkova et al. 2006; Di Micco et al. 2006).”
Background
Cited by
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
“, perhaps acting as a 'safety net' for rapidly proliferating cells, but sustained cyclin D1–CDK4 activity following DNA damage leads to the inappropriate re-replication of DNA and chromosomal damag”
BackgroundGaillard, H., García-Muse, T., & Aguilera, A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3916 · Cited by 1,089
Targeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
Cyclin D1, cancer progression, and opportunities in cancer treatment
Qie, S., & Diehl, J. A. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1475-3 · Cited by 657
“Investigation of the mechanisms that underscore nuclear cyclin D1-dependent neoplastic growth revealed overexpression of the constitutively nuclear and stable cyclin D1 (T286A), but not wild-type cyclin D1, which promotes stabilization and mis-expression of the DNA replication licensing factor Cdt1, which then trigger…”
BackgroundSelf-citationNon-canonical functions of cell cycle cyclins and cyclin-dependent kinases
Hydbring, P., Malumbres, M., & Sicinski, P. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.27 · Cited by 528
Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
Kotsantis, P., Petermann, E., & Boulton, S. J. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1461 · Cited by 416
“Furthermore, overexpression of a constitutively nuclear mutant form of CYCLIN D1 induces CDT1 stabilization that promotes relicensing and rereplication (107).”
BackgroundNuclear cyclin D1: an oncogenic driver in human cancer
Kim, J. K., & Diehl, J. A. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21791 · Cited by 413
“Recently, we provided the first experimental evidence linking the constitutively nuclear cyclin D1/CDK4 complex with induction of genomic instability in mouse models and human cancer-derived cells (Aggarwal et al., 2007).”
BackgroundSelf-citationThe double dealing of cyclin D1
Tchakarska, G., & Sola, B. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1706903 · Cited by 278
“In the Eμ-CCND1 T285A transgenic mouse model, malignant lymphocytes display aneuploidy and chromosomal translocation due to alterations in DNA replication [85].”
BackgroundInfluentialAggarwal, P., Vaites, L. P., Kim, J. K., Mellert, H., Gurung, B., Nakagawa, H., Herlyn, M., Hua, X., Rustgi, A. K., McMahon, S. B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.012 · Cited by 242
“Cell Culture, Transfections, and Plasmids Cell culture conditions and transfections were performed as previously noted (Aggarwal et al., 2007).”
InfluentialSelf-citationReplication licensing and cancer — a fatal entanglement?
Blow, J. J., & Gillespie, P. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2500 · Cited by 228
Siwecka, N., Rozpędek, W., Pytel, D., Wawrzynkiewicz, A., Dziki, A., Dziki, Ł., Diehl, J. A., & Majsterek, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184354 · Cited by 200
“This phenomenon can be explained by overexpression of cyclin D1 and repression of CHOP translation in PERK+/− mutant cells [220,221].”
BackgroundSelf-citationPestell, R. G. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.03.001 · Cited by 197
Martínez-Alonso, D., & Malumbres, M. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.03.009 · Cited by 179
Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR
Schoppy, D. W., Ragland, R. L., Gilad, O., Shastri, N., Peters, A. A., Murga, M., Fernandez-Capetillo, O., Diehl, J. A., & Brown, E. J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58928 · Cited by 182
Self-citationDNA replication stress mediates APOBEC3 family mutagenesis in breast cancer
Kanu, N., Cerone, M. A., Goh, G., Zalmas, L.-P., Bartkova, J., Dietzen, M., McGranahan, N., Rogers, R., Law, E. K., Gromova, I., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1042-9 · Cited by 165
Chao, C. C. ‐. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.015 · Cited by 168
CRL4Cdt2: Master coordinator of cell cycle progression and genome stability
Abbas, T., & Dutta, A. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14530 · Cited by 143
PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers
Li, Y., Chitnis, N., Nakagawa, H., Kita, Y., Natsugoe, S., Yang, Y., Li, Z., Wasik, M., Klein-Szanto, A. J. P., Rustgi, A. K., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0625 · Cited by 143
“MYC – ICN + PRMT5 1 2 3 4 1 2 3 4 5 1 2 3 4 5 meR-p53 IgG control Normal (13-12521)”
Self-citationBarbash, O., Zamfirova, P., Lin, D. I., Chen, X., Yang, K., Nakagawa, H., Lu, F., Rustgi, A. K., & Diehl, J. A. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.017 · Cited by 140
“As expected with the nuclear accumulation of cyclin D1, Cdt1 was overexpressed following knockdown of either Fbx4 or aB-crystallin (Figure 5C).”
InfluentialSelf-citationMUC1 regulates nuclear localization and function of the epidermal growth factor receptor
Bitler, B. G., Goverdhan, A., & Schroeder, J. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.062661 · Cited by 136
“Jo ur na l o f C el l S ci en ce in 30% of breast cancer, which leads to increased proliferation and genetic instability in both in vivo and in vitro models of breast cancer (Aggarwal et al., 2007; Gillett et al., 1994).”
BackgroundAlternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response
Li, Z., Jiao, X., Wang, C., Shirley, L. A., Elsaleh, H., Dahl, O., Wang, M., Soutoglou, E., Knudsen, E. S., & Pestell, R. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0312 · Cited by 124
Replication Licensing Aberrations, Replication Stress, and Genomic Instability
Petropoulos, M., Tsaniras, S. C., Taraviras, S. L., & Lygerou, Z. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.03.011 · Cited by 129
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60256 · Cited by 115
“However, cyclin D1 overexpression correlated with aneuploidy, supernumerary centrosomes, and spindle defects in mouse hepatocytes (41) and with aneuploidy and polyploidy in lymphoid tumors (42).”
Qie, S., Yoshida, A., Parnham, S., Oleinik, N., Beeson, G. C., Beeson, C. C., Ogretmen, B., Bass, A. J., Wong, K.-K., Rustgi, A. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09179-w · Cited by 104
Self-citationPrevention of DNA re-replication in eukaryotic cells
Truong, L. N., & Wu, X. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq052 · Cited by 119
“The human esophageal carcinoma-derived cell lines TE3 and TE7, harboring the cyclin D1-P287A mutation express Cdt1 5–6-fold higher than the control cell lines due to disruption of the Cul4–Ddb1–Cdt2-mediated Cdt1 degradation pathway (Aggarwal et al., 2007).”
BackgroundAcquired Radioresistance of Cancer and the AKT/GSK3β/cyclin D1 Overexpression Cycle
SHIMURA, T. (2011) · Journal of Radiation Research · doi:10.1269/jrr.11098 · Cited by 93
Restriction point regulation at the crossroads between quiescence and cell proliferation
Pennycook, B. R., & Barr, A. R. (2020) · FEBS Letters · doi:10.1002/1873-3468.13867 · Cited by 92
Pontano, L. L., Aggarwal, P., Barbash, O., Brown, E. J., Bassing, C. H., & Diehl, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01085-08 · Cited by 71
“Transgenic mice expressing cyclin D1T286A driven by the E enhancer develop B-cell lymphomas with significant aneuploidy and chromosomal translocations (2).”
BackgroundResultSelf-citationLange, T. S., Kim, K., Singh, R. K., Strongin, R. M., McCourt, C. K., & Brard, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002303 · Cited by 76
“With respect to S-phase events both mouse models and studies on cancer-derived cells revealed that accumulation of cyclin D1/CDK4 complexes triggers DNA re-replication [36] and, thus, could be specifically targeted in cancer cells.”
BackgroundMiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1
Li, Z., Wang, H., Wang, Z., & Cai, H. (2015) · Tumor Biology · doi:10.1007/s13277-015-4540-6 · Cited by 67
Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma
Qie, S., Majumder, M., Mackiewicz, K., Howley, B. V., Peterson, Y. K., Howe, P. H., Palanisamy, V., & Diehl, J. A. (2017) · Nature Communications · doi:10.1038/s41467-017-01199-8 · Cited by 69
Self-citationShimura, T., Ochiai, Y., Noma, N., Oikawa, T., Sano, Y., & Fukumoto, M. (2013) · Cell Cycle · doi:10.4161/cc.23719 · Cited by 67
“It has been reported that the accumulation of cyclin D1 in the nucleus loads replicative MCM helicase onto the chromatin and triggers DNA re-replication, which is required for Cdk4 activity.(24) Our results revealed that Cdk4 inactivation did not affect the amount of DSBs in the 31FR-31NR cells.”
BackgroundPhosphorylation of MCM3 on Ser-112 regulates its incorporation into the MCM2–7 complex
Lin, D. I., Aggarwal, P., & Diehl, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800077105 · Cited by 63
Self-citationKim, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1198 · Cited by 60
DNA Replication Stalling Attenuates Tyrosine Kinase Signaling to Suppress S Phase Progression
Shields, B. J., Hauser, C., Bukczynska, P. E., Court, N. W., & Tiganis, T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.003 · Cited by 64
The Shh Receptor Boc Promotes Progression of Early Medulloblastoma to Advanced Tumors
Mille, F., Tamayo-Orrego, L., Lévesque, M., Remke, M., Korshunov, A., Cardin, J., Bouchard, N., Izzi, L., Kool, M., Northcott, P. A., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.08.010 · Cited by 65
The Fbx4 Tumor Suppressor Regulates Cyclin D1 Accumulation and Prevents Neoplastic Transformation
Vaites, L. P., Lee, E. K., Lian, Z., Barbash, O., Roy, D. B., Wasik, M. A., Klein–Szanto, A. J., Rustgi, A. K., & Diehl, J. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05733-11 · Cited by 55
“7C), and Fbx4 / MEFs exhibit Cdt1 stabilization in S phase, with a concomitant reduction in Cul4 levels (Fig.”
BackgroundInfluentialSelf-citationDNA replication licensing proteins: Saints and sinners in cancer
Jameel, M., Mahadevappa, R., & Kwok, H. F. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.009 · Cited by 55
Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells
Çağlar, H. O., & Avcı, Ç. B. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05341-6 · Cited by 59
“suggested that p53 inactivation with high CCND1 expression is also a requirement for induced genomic instability [54].”
An mRNA expression-based signature for oncogene-induced replication-stress
Llobet, S. G., Bhattacharya, A., Everts, M., Kok, K., van der Vegt, B., Fehrmann, R. S. N., & van Vugt, M. A. T. M. (2022) · Oncogene · doi:10.1038/s41388-021-02162-0 · Cited by 53
Lou, X., Zhang, J., Liu, S., Lou, X., & Liao, D. J. (2014) · Cell Cycle · doi:10.4161/cc.29082 · Cited by 51
Rieck, S., Zhang, J., Li, Z., Liu, C., Naji, A., Takane, K. K., Fiaschi‐Taesch, N., Stewart, A. F., Kushner, J. A., & Kaestner, K. H. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1019 · Cited by 55
“Also, increased expression of Cdt1 and subsequent rereplication occurs in human cancer-derived cell lines upon accumulation of constitutively active mutant form of Cyclin D1 (35).”
BackgroundOrr, S. J., Gaymes, T. J., Ładoń, D., Chronis, C., Czepulkowski, B. H., Wang, R., Mufti, G. J., Marcotte, E. M., & Thomas, N. S. B. (2010) · Oncogene · doi:10.1038/onc.2010.138 · Cited by 48
“Expression of nuclear cyclin D1 leads to an increase in Cdt1 expression, increased MCM loading, re-replication and genomic instability (Aggarwal et al., 2007).”
BackgroundPytel, D., Gao, Y., Mackiewicz, K., Katlinskaya, Y. V., Staschke, K. A., Paredes, M. C. G., Yoshida, A., Qie, S., Zhang, G., Chajewski, O. S., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006518 · Cited by 48
Self-citationExosome Release Delays Senescence by Disposing of Obsolete Biomolecules
Zou, W., Lai, M., Jiang, Y., Mao, L., Wu, Z., Zhang, S., Lai, P., Guo, B., Wei, T., Nie, C., et al. (2023) · Advanced Science · doi:10.1002/advs.202204826 · Cited by 52
Abdelmalak, M., Singh, R., Anwer, M. I., Ivanchenko, P., Randhawa, A., Ahmed, M., Ashton, A. W., Du, Y., Jiao, X., & Pestell, R. G. (2022) · Cancers · doi:10.3390/cancers14215388 · Cited by 50
Aberrant Expression of Cyclin D1 in Cancer
Inoue, K., & Fry, E. A. (2015) · Signal Transduction Insights · doi:10.4137/sti.s30306 · Cited by 51
“They showed that the tumor cells had increased histone arginine methylation (56), CDT1 overexpression, CUL4 repression, and DNA re-replication (57) reflecting increased PRMT5 activity.”
BackgroundDNA Replication Stress and Cancer: Cause or Cure?
Taylor, E. M., & Lindsay, H. D. (2015) · Future Oncology · doi:10.2217/fon.15.292 · Cited by 49
Shimura, T., & Kunugita, N. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1170271 · Cited by 46
“tion and suppression of replication fork progression leading to DSBs.(72,73) Perturbation of cyclin D1 expression is associated with”
BackgroundCRL4Cdt2: Coupling Genome Stability to Ubiquitination
Παναγόπουλος, Α., Taraviras, S. L., Nishitani, H., & Lygerou, Z. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.005 · Cited by 47
Cell Cycle Regulators Guide Mitochondrial Activity in Radiation-Induced Adaptive Response
Alexandrou, A. T., & Li, J. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5684 · Cited by 43
“…irradiated Sprague Dawley rats; the results showed that levels of key proteins involved in mitochondrial fatty acid metabolism were reduced, and proteins involved in various cellular defense mechanisms, including antioxidants, were elevated in both irradiated and nonirradiated tissues (2, 81).”
Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer
Sante, G. D., Rocco, A. D., Pupo, C., Casimiro, M. C., & Pestell, R. G. (2017) · Oncotarget · doi:10.18632/oncotarget.19413 · Cited by 44
“Furthermore, forced expression of a degradation defective cyclin D1a mutant induced the DDR in murine lymphoid tissue [76].”
BackgroundCyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis
Gan, L., Liu, P., Lu, H., Chen, S., Yang, J., McCarthy, J. B., Knudsen, K. E., & Huang, H. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.86 · Cited by 44
“It has been shown that in comparison to wild-type cyclin D1, exogenous expression of cancer-derived mutants of cyclin D1 accelerates cell transformation in vitro and tumor formation in mice.(32,34) However, the mechanism by which such cancer-derived mutants of cyclin D1 function as potent oncogenes is poorly understoo…”
Xu, J. L., & Lin, D. I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199688 · Cited by 42
“Accumulating evidence also suggests that mutations of the CCND1 gene that result in nuclear retention and constitutive activation of CDK4/6 kinases are oncogenic drivers in cancer [6][7] [8][9].”
Self-citationDegradation strategy of cyclin D1 in cancer cells and the potential clinical application
Chen, S., & Li, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.949688 · Cited by 47
“When dysregulated, upregulated cyclin D1 antagonizes the checkpoint induced cell cycle arrest, disturbs DNA replication, and allows damaged DNA to be repl icated (4 , 10, 11) .”
BackgroundIn the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?
Moore, J. D. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3468 · Cited by 50
The clinical and molecular significance associated with STING signaling in breast cancer
Parkes, E. E., Humphries, M. P., Gilmore, E. S., Sidi, F. A., Bingham, V., Phyu, S. M., Craig, S. G., Graham, C., Miller, J. J., Griffin, D., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00283-z · Cited by 37
The FBXO4 Tumor Suppressor Functions as a Barrier to Braf V600E -Dependent Metastatic Melanoma
Lee, E. K., Lian, Z., D'Andrea, K. P., Letrero, R., Sheng, W., Liu, S., Diehl, J. A., Pytel, D., Barbash, O., Schuchter, L. M., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00706-13 · Cited by 39
“Importantly, Fbxo4 deficiency leads to nuclear accumulation of cyclin D1, which in turn promotes cyclin D1-dependent cellular transformation (23, 26, 27).”
BackgroundSelf-citationChen, H., Xu, X., Wang, G., Zhang, B., Wang, G., Xin, G., Liu, J., Jiang, Q., Zhang, H., & Zhang, C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773226 · Cited by 39
CUL4B promotes proliferation and inhibits apoptosis of human osteosarcoma cells
Chen, Z., SHEN, B.-L., Fu, Q., Wang, F., Tang, Y., Hou, C., & Chen, L. (2014) · Oncology Reports · doi:10.3892/or.2014.3465 · Cited by 35
The role of cyclin D1 in response to long-term exposure to ionizing radiation
Shimura, T., Fukumoto, M., & Kunugita, N. (2013) · Cell Cycle · doi:10.4161/cc.25746 · Cited by 38
“In contrast, overexpressing cyclin D1 using a cyclin D1 expression vector triggered DNA re-replication and induced DSBs in a Cdk4-dependent manner.(21) Therefore, FR-induced DSBs were not induced by DNA re-replication, but were induced by suppressing replication fork movement.”
BackgroundBirner, P., Schoppmann, A., Schindl, M., Dinhof, C., Jesch, B., Berghoff, A. S., & SCHOPPMANN, S. F. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200463 · Cited by 36
Barbash, O., Egan, E., Pontano, L. L., Kosak, J., & Diehl, J. A. (2009) · Oncogene · doi:10.1038/onc.2009.287 · Cited by 37
Self-citationBarbash, O., Lee, E. K., & Diehl, J. A. (2011) · Oncogene · doi:10.1038/onc.2010.584 · Cited by 33
“Nuclear accumulation of cyclin D1, particularly in S phase, is now appreciated to directly contribute to genomic instability and drive transformation (Aggarwal et al., 2007).”
BackgroundInfluentialSelf-citationMechanisms and clinical applications of chromosomal instability in lymphoid malignancy
Krem, M. M., Press, O. W., Horwitz, M. S., & Tidwell, T. J. (2015) · British Journal of Haematology · doi:10.1111/bjh.13507 · Cited by 34
“It is thought that DSBs accumulate, leading to CIN (Derenzini et al, 2015).”
BackgroundInfluentialTruong, L. N., Li, Y., Sun, E., Ang, K., Hwang, P. Y.-H., & Wu, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576488 · Cited by 30
“Importantly, certain oncogenes, such as H-RasV12 and CycD1-P287A disrupt the licensing control and induce DNA rereplication (60, 61).”
BackgroundBraden, W. A., McClendon, A. K., & Knudsen, E. S. (2008) · Oncogene · doi:10.1038/onc.2008.319 · Cited by 30
“Interestingly, recent studies indicate that this degradation process is modulated by nuclear localization of cyclin D1, such that CDK4/6/cyclin D1 activity stabilizes cdt1 (Aggarwal et al., 2007).”
BackgroundRetractedYadav, A. K., & Polášek-Sedláčková, H. (2024) · Communications Biology · doi:10.1038/s42003-024-05855-w · Cited by 29
It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53
Love, I. M., & Grossman, S. R. (2012) · Genes & Cancer · doi:10.1177/1947601912455198 · Cited by 32
Flipping the Switch from G1 to S Phase with E3 Ubiquitin Ligases
Rizzardi, L. F., & Cook, J. G. (2012) · Genes & Cancer · doi:10.1177/1947601912473307 · Cited by 32
“Interestingly, nuclear accumulation of active Cyclin D1/Cdk4 indirectly promotes Cdt1 stabilization in S phase through transcriptional repression of Cul4 by an unknown mechanism.(177) The SCF E3 ubiquitin ligase has been implicated in targeting phosphorylated Cyclin D1 for proteolysis at the G1/S transition.”
BackgroundFbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3
Yoshida, A., Choi, J., Jin, H. R., Li, Y., Bajpai, S., Qie, S., & Diehl, J. A. (2020) · Oncogene · doi:10.1038/s41388-020-01532-4 · Cited by 26
Self-citationDNA damage-dependent cyclin D1 proteolysis: GSK3β holds the smoking gun
Pontano, L. L., & Diehl, J. A. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7889 · Cited by 26
Self-citationCyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation
Chalermrujinanant, C., Michowski, W., Sittithumcharee, G., Esashi, F., & Jirawatnotai, S. (2015) · Oncogene · doi:10.1038/onc.2015.354 · Cited by 25
Consequence of the tumor-associated conversion to cyclin D1b
Augello, M. A., Berman‐Booty, L. D., Carr, R., Yoshida, A., Dean, J. L., Schiewer, M. J., Feng, F. Y., Tomlins, S. A., Gao, E., Koch, W. J., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404242 · Cited by 23
“Furthermore, mutations in the cyclin D1 PEST domain have been shown to promote cyclin D1a stability, which resulted in inappropriate expression throughout the cell cycle, culminating in aberrant assembly of replication machinery and DNA damage signals (Aggarwal et al, 2007).”
BackgroundSelf-citationFRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation
Hua, L., Zhu, M., Xu, S., Wang, J., Fang, Z. Y., Zhang, C., Shi, Q., Zhan, W., Wang, L., Meng, Q., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1461-y · Cited by 23
Vaites, L. P., Lian, Z., Lee, E. K., Yin, B., DeMicco, A., Bassing, C. H., & Diehl, J. A. (2013) · Oncogene · doi:10.1038/onc.2012.577 · Cited by 22
Self-citationShimura, T., Hamada, N., Sasatani, M., Kamiya, K., & Kunugita, N. (2014) · Cell Cycle · doi:10.4161/cc.28139 · Cited by 21
“, DNA re-replication and the suppression of replication-fork progression, lead to DSBs.(15,20) Here we observed that normal human fibroblasts exposed to long-term FR accumulated nuclear cyclin D1 and suffered chromosome damage in the form of micronuclei (Fig.”
BackgroundInfluentialChen, X., Zhang, L., Zheng, S., Zhang, T., Li, M., Zhang, X., Zeng, Z., McCrae, M. A., Zhao, J., Zhuang, H., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0384 · Cited by 22
“Inmouse models and human cancer-derived cells, the cyclinD1–T286A/CDK4 complex was found to be able to trigger DNA rereplication during S phase, resulting fromCdt1 stabilization, which in turn induced genomic instability characterized by aneuploidy (33).”
BackgroundPreventing excess replication origin activation to ensure genome stability
Thakur, B. L., Ray, A., Redon, C. E., & Aladjem, M. I. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.09.008 · Cited by 21
Pontano, L. L., & Diehl, J. A. (2008) · Cell Division · doi:10.1186/1747-1028-3-12 · Cited by 20
“Consistent with this notion, cyclin D1T286A-dependent tumorigenesis is accompanied by activation of the DNA damage checkpoint pathway and loss of p53 [31].”
BackgroundSelf-citationNavarro, A., Royo, C., Hernández, L., Jares, P., & Campo, E. (2011) · Seminars in Hematology · doi:10.1053/j.seminhematol.2011.04.001 · Cited by 20
Lin, H., Wu, J., Tan, B. C., & Chien, C. (2009) · Journal of Cell Science · doi:10.1242/jcs.042861 · Cited by 17
“This Cdt1 stabilization could be suppressed by the overexpression of Cul4A and Cul4B but not DDB1 or Cdt2, also an adaptors for the Cul4 ligases, implying the involvement of other adaptors in mediating the Cul4-dependent degradation of Cdt1 (Aggarwal et al., 2007).”
BackgroundTsukahara, T., Haniu, H., & Matsuda, Y. (2014) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-014-0224-2 · Cited by 16
“Cyclin D1 is a key cell cycle regulatory protein, and its expression and subcellular localization is often altered in colon cancer cells [23–25].”
BackgroundExploring replication stress and cellular senescence as key targets in novel cancer therapies
Ray, S. K., & Mukherjee, S. (2025) · Cancer Genetics · doi:10.1016/j.cancergen.2025.09.002 · Cited by 15
Madakashira, B. P., Magnani, E., Ranjan, S., & Sadler, K. C. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae031 · Cited by 15
“Further, Cyclin D1 / CDK4 activation during S-phase specifically represses transcription of CUL4, resulting in CDT1 stabilization ( 97 ).”
BackgroundARF inhibits the growth and malignant progression of non-small-cell lung carcinoma
Busch, S., Moser, R. D., Gurley, K. E., Kelly‐Spratt, K. S., Liggitt, H. D., & Kemp, C. J. (2013) · Oncogene · doi:10.1038/onc.2013.208 · Cited by 17
DNA replication licensing control and rereplication prevention
Li, C., & Jin, J. (2010) · Protein & Cell · doi:10.1007/s13238-010-0032-z · Cited by 15
“Interestingly, Cyclin D1-induced rereplication is accelerated by inactivation of p53 (Aggarwal et al., 2007), while p53 can prevent rereplication triggered by over-expressing both Cdt1 and Cdc6 (Vaziri et al., 2003).”
BackgroundInfluentialRecurrent cyclin D2 mutations in myeloid neoplasms
Khanna, V., Eide, C. A., Tognon, C. E., Maxson, J. E., Wilmot, B., Bottomly, D., McWeeney, S. K., Edwards, D. K., V, Druker, B. J., & Tyner, J. W. (2017) · Leukemia · doi:10.1038/leu.2017.195 · Cited by 15
A clinical evaluation of treatments that target cell cycle machinery in breast cancer
Fedele, P., Sanna, V., Fancellu, A., & Cinieri, S. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1672659 · Cited by 16
Unbalanced replication as a major source of genetic instability in cancer cells.
Corcos, D. (2012) · PubMed Central · Cited by 18
Sertic, S., Evolvi, C., Tumini, E., Plevani, P., Muzi-Falconi, M., & Rotondo, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060000 · Cited by 14
“Accordingly with the idea that DNA re-replication is a cancer inducer [29], we also show that cells with overreplicated DNA induced by CRL4A/4B inactivation escape apoptosis.”
BackgroundRojas, P. A., Benavides, F. J., Blando, J. M., Pérez, C. J., Cardenas, K. T., Richie, E. R., Knudsen, E. S., Johnson, D. G., Senderowicz, A. M., Rodríguez‐Puebla, M. L., et al. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20489 · Cited by 15
“suggests that nuclear accumulation of cyclin D1 inhibits CDT1 proteolysis resulting in aneuploidy and genome instability [41].”
BackgroundPRMT5-dependent p53 escape in tumorigenesis
Li, Y., & Diehl, J. A. (2015) · Oncoscience · doi:10.18632/oncoscience.222 · Cited by 13
“In EmD1T286A transgenic mice, DNA-damage induced by nuclear D1T286A/CDK4 triggers ATM–CHK2–p53dependent apoptosis in the premalignant transgenic mice and breach of this barrier could be achieved by genetic deletion of p53 [9,10].”
BackgroundSelf-citationDemchenko, Y. N., Roschke, A. V., Chen, W.-D. D., Asmann, Y. W., Bergsagel, P. L., & Kuehl, W. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw527 · Cited by 11
“Given that dysregulation of a CYCLIN D gene is present in virtually all MGUS and MM tumors (1,34), it notable that a high level CYCLIN D1 expression has been shown to be associated with re-replication (35).”
BackgroundYoshida, A., Phillips‐Mason, P. J., Tarallo, V., Avril, S., Koivisto, C. S., Leone, G. W., & Diehl, J. A. (2022) · Oncogene · doi:10.1038/s41388-022-02243-8 · Cited by 12
“We previously demonstrated that cyclin D1 overexpression causes DNA damage, leading to genomic instability, which in turn, develops tumors [10, 12].”
Self-citationRuiz-Miró, M., Colomina, N., Fernández-Hernández, R., Garí, E., Gallego, C., & Aldea, M. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01176.x · Cited by 11
“Although disruption of cyclin D1 is able to restrict mammary and gastrointestinal tumor growth (32,33), overexpression of cyclin D1 is not sufficient for tumorogenesis, and it seems clear that nuclear accumulation of cyclin D1 because of altered nuclear trafficking or degradation also plays an important role in cancer…”
BackgroundQie, S. (2022) · Cancers · doi:10.3390/cancers14092133 · Cited by 10
Xu, S., Liu, D., Cui, M., Zhang, Y., Zhang, Y., Guo, S., & Zhang, H. (2022) · BioMed Research International · doi:10.1155/2022/1893351 · Cited by 10
“This caused DNA rereplication and damage and resulted in cellular aneuploidy, genomic instability, and further neoplastic growth [39].”
BackgroundRetractedRajesh, A., Havas, A. P., Arnold, R., Lande, K., Lei, X., Li, K. Y., Gandhi, A., Franco, A. C., Woo, S., Lagnado, A. B., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01196-x · Cited by 10
“This interpretation is consistent with the known capacity of CCND1 overexpression to induce replication stress and DNA double-strand breaks 74–76 and with the broader principle that oncogene-driven replication stress is a primary trigger of senescence entry 3,5 .”
Maisel, S. A., & Schroeder, J. A. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.82 · Cited by 13
“EGFR has also been shown to interact with cyclin D1 in the nucleus and cyclin D1 expression is increased in EGFR-dependent mouse models and breast cancers([56,95-97]).”
Metadata
- Authors
- Aggarwal, P., Lessie, M. D., Lin, D. I., Pontano, L., Gladden, A. B., Nuskey, B., Goradia, A., Wasik, M. A., Klein-Szanto, A. J. P., Rustgi, A. K., Bassing, C. H., & Diehl, J. A.
- Affiliations
- University of Pennsylvania (US)
- Children's Hospital of Philadelphia (US)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2007-11-15
- Volume
- 21
- Issue
- 22
- Pages
- 2908-2922
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC2049193
- OpenAlex
- W2112318168
- Cited by
- 132
- References
- 67
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 6 · 2018: 4 · 2017: 8 · 2016: 8 · 2015: 12 · 2014: 10 · 2013: 11 · 2012: 9
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA098101)
- National Cancer Institute (P01CA098101, R01CA093237, CA 93237)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cyclin D1, Cdt1, CUL4, DNA re-replication, p53, DNA damage checkpoint, apoptosis, genomic instability, oncogenic transformation, S phase, DNA replication fidelity
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, DNA, DNA Replication, DNA-Binding Proteins, DNA, Neoplasm, HeLa Cells, Humans, Hydrolysis, Lipopolysaccharides, Mice, Transgenic, Mutation, Osteosarcoma, Spleen, Tumor Suppressor Protein p53, S Phase, Cell Cycle Proteins, Cyclin D1, NIH 3T3 Cells, Cullin Proteins, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.